The severity and complexity of depression can vary widely among individuals, thus making single drug therapy ineffective in some cases. Taking this fact into account and using a mouse model, we set on investigating the possibility of obtaining a synergism of action between a classical tricyclic antidepressant that inhibits noradrenalin and serotonin reuptake (doxepin), and a modern antidepressant that inhibits type-B monoamine oxidase (selegiline). We measured the antidepressant effect using the forced swimming test and the tail suspension test. We determined motor activity using the Activity Cage test. Our results have shown that the antidepressant effect intensifies significantly in the animals treated with both antidepressants simultaneously compared to those treated only with doxepin. Furthermore, we observed that selegiline decreases the sedative effect of doxepin in the Activity Cage test.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Chiriță, Cornel; Ștefănescu, Emil; Zbârcea, Cristina E.; Mireșan, Horațiu; Negreș, Simona; Nuță, Diana C.; Limban, Carmen; Dănciulescu Miulescu, Rucsandra E.; and Marineci, Cristina D.
"Experimental pharmacological research regarding the antidepressant effect of associating doxepin and selegiline in normal mice,"
Journal of Mind and Medical Sciences: Vol. 6
, Article 13.
Available at: https://scholar.valpo.edu/jmms/vol6/iss2/13